PharmaShots | Incisive News in 3 Shots

Subscribe Now

Option

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for Antibody-Drug Conjugate Candidates

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for Antibody-Drug Conjugat...

October 21, 2021

Boehringer Ingelheim Exercised its Option to License Oxford Biomedica's Lentiviral Vector Technology to Commercialize BI 3720931 for CF

Boehringer Ingelheim Exercised its Option to License Oxford Biomedica's Lentiviral Vector Technology to Commercialize BI 3720931 f...

October 20, 2021

Takeda to Acquire Maverick for ~$525M

Takeda to Acquire Maverick for ~$525M

March 10, 2021

Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

November 12, 2020

Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

October 28, 2020

Bausch Health Acquires Option to Purchase Allegro's Ophthalmology Assets

Bausch Health Acquires Option to Purchase Allegro's Ophthalmology Assets

September 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us